NEW YORK (GenomeWeb News) – General Electric unit GE Healthcare announced today that it has entered into a strategic alliance agreement with Fujifilm.
Under the agreement, Fujifilm will develop, manufacture, and supply biomolecular imaging systems to GE Healthcare, which will sell the products in life science and drug discovery markets around the world under the GE brand.
Fujifilm has developed a range of biomolecular imaging products over the years — from digital autoradiography devices to CCD camera systems. GE Healthcare, meanwhile, has introduced various non-radioactive biomolecular labeling and detection products.
In a statement today, Fujifilm Director and General Manager of the Life Science Products Division Yuzo Toda said that the agreement with GE Healthcare will combine Fujifilm's technology, R&D, and manufacturing with GE Healthcare's presence as a reagent and instrument supplier.
"By forming the alliance, both companies will make the most of our complementary capabilities to continue to the advancement of genomic and protein research," he said.
Nigel Darby, general manager of biotechnologies, life sciences at GE Healthcare, said that the FujiFilm products "fit well with our proprietary labeling technologies and the adjacent fields in the imaging workflow that GE Healthcare currently addresses."
Financial and other terms of the agreement were not disclosed.